Atherosclerotic and Cardiometabolic Disease

<p>In recent years important progress has been made in the field of molecular biology concerning atherogenesis. However there are still gaps in current knowledge regarding its underlying pathogenesis. Moreover various diseases such as non-alcoholic fatty liver disease/steatohepatitis diabetes mellitus arterial hypertension dyslipidemia and metabolic syndrome are tightly connected with atherosclerosis sharing at least in part common molecular pathogenetic mechanisms.</p><p>Although cardiovascular diseases (CVDs) still remain the leading cause of death globally lifestyle modification interventions as well as pharmacological therapies (e.g. anti-hypertensive lipid-lowering drugs) and advances in cardiovascular surgery have led to a reduction in CVD mortality.</p><p>This reprint of a Special Issue aims to provide new data and discuss recent advances in the field of atherosclerosis and atherosclerosis-related diseases. An improved understanding of the common pathophysiological processes that result in cardio-metabolic diseases will help in the identification of effective prevention strategies and the development of innovative therapeutic targets which can be introduced in routine clinical practice.</p>